scispace - formally typeset
J

Jon Clardy

Researcher at Harvard University

Publications -  990
Citations -  62414

Jon Clardy is an academic researcher from Harvard University. The author has contributed to research in topics: Absolute configuration & Bacteria. The author has an hindex of 116, co-authored 983 publications receiving 56617 citations. Previous affiliations of Jon Clardy include Howard Hughes Medical Institute & University of Chicago.

Papers
More filters
Journal ArticleDOI

Letter: Structure and synthesis of verruculotoxin, a new mycotoxin from Penicillium verruculosum Peyronel.

James G. Macmillan, +4 more
- 07 Jan 1976 - 
Journal ArticleDOI

The dichlorovinylation of enolates

Andrew S. Kende, +5 more
- 01 Jan 1979 - 
TL;DR: In this paper, the trans stereochemistry for one such product is established by X-ray, and subsequent transformations of these initial products to ethinyl or ω-chloroethinyl derivatives is described.
Journal ArticleDOI

Novel triterpenoids from the roots of Buxus papillosa

Atta-ur-Rahman, +6 more
- 01 Jan 1992 - 
TL;DR: In this paper, three new compounds have been isolated from the roots of Buxus papillosa and the structures of thes steroidal compounds were determined by using X-ray diffraction and spectroscopic techniques.
Journal ArticleDOI

Three pregnane-10,2-carbolactones from a sponge, Strongylophora sp.

Jay M. Corgiat, +3 more
- 01 Jan 1993 - 
TL;DR: In this paper, three pregnanes, 3,4-dihydroxypregna-5,17-diene-10,2-carbolactone (1), 3, 4-dhydroxymregna -5,15-dien-20-one-10-1,10-2-CARBOLACTONE (3, 4dhd-roxymrgna)-5,20diene -10, 2-carboractone, and 3h4dhdyroxymgna-1
Journal ArticleDOI

Dihydroquinazolinone Inhibitors of Proliferation of Blood and Liver Stage Malaria Parasites

Emily R. Derbyshire, +7 more
- 01 Mar 2014 - 
TL;DR: Evaluation of a 259-member library of compounds that block proliferation of the blood stage of malaria revealed several scaffolds—dihydroquinazolinones, phenyldiazenylpyridines, piperazinyl methyl quinolones, and bis-benzimidazoles—with promising activity against the liver stage.